Sensory responses of neurons in the medial septal area in conditions of modulation of theta activity using the alpha-2-adrenoreceptor agonist clonidine.
Our previous studies on conscious rabbits showed that administration of the alpha-2-adrenoreceptor agonist clonidine induces dose-dependent changes in theta oscillations in the septohippocampal system. Low doses of clonidine suppressed theta activity, while high doses produced significant potentiation. It was suggested that the different effects of clonidine might be associated with differences in the sensitivities of pre- and postsynaptic alpha-2-adrenoreceptors to clonidine, this agent being a pure agonist of noradrenaline when used at high doses. It was suggested that functional synergism occurs between the activatory reticular formation and the noradrenergic system of the locus ceruleus in controlling the theta rhythm. The present study was performed to identify the nature of the responses of sensory neurons in the medial septal region in conditions of alterations in the magnitude of the theta rhythm induced by different doses of clonidine. Low and high doses of the agonist given bilaterally into the lateral ventricles were found to have different effects on the sensory responses of neurons in the medial septal region. Injection of small clonidine doses (0.5 microg in 5 microl into each lateral ventricle), which decrease theta activity, was found to lead to weakening of activatory processes and enhancement of inhibitory processes in the medial septal region. The number of activatory responses decreased significantly and persisting responses were significantly weakened; inhibitory responses, conversely, were seen more frequently and were significantly more marked. Administration of high clonidine doses (5 microg in 5 microl), which produce sharp increases in theta oscillations, led to significant reductions in the reactivity of cells in the medial septal region to sensory stimuli (from 76.8% in controls to 45% after clonidine), regardless of the nature of the initial responses. Persisting activatory and inhibitory responses were in most cases less marked than the initial responses. These results suggest that alpha-2-adrenoreceptors are involved in controlling the sensory reactivity of neurons in the medial septal region. The impairment of the normal processing of sensory stimuli seen during the continuous generation of rhythmic activity provoked by injection of large clonidine doses supports the role of the theta rhythm in the septohippocampal system as an active filter during the processing and recording of information.
Kichigina
V F
VF
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences. Kichigina@iteb.ru
Kutyreva
E S
ES
Sudnitsyn
V V
VV
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D003000:Clonidine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D009475:Neurons, Afferent / Q000187:drug effects* / Q000502:physiology; D010812:Physical Stimulation / Q000379:methods; D011817:Rabbits; D020665:Septum of Brain / Q000166:cytology* / Q000187:drug effects; D013826:Theta Rhythm / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D003000:Clonidine
J Neurosci. 1989 Jun;9(6):2131-40
2542486
Neuroscience. 1990;39(2):431-9
2087265
Neuropharmacology. 1996 Jun;35(6):679-87
8887976
Prog Neuropsychopharmacol Biol Psychiatry. 1987;11(4):419-58
3321150
Eur J Neurosci. 2000 Jan;12(1):264-72
10651881
J Neurophysiol. 1997 Jun;77(6):3326-39
9212278
Neurochem Res. 1997 Aug;22(8):957-66
9239751
Neuroscience. 1984 Nov;13(3):819-25
6084829
Brain Res. 1979 Mar 16;163(2):223-34
218681
Prog Neurobiol. 1995 Apr;45(6):523-83
7624485
Brain Res. 1980 Sep 29;198(1):95-117
7407597
Neuroscience. 1993 Apr;53(4):993-1007
8506032
Neuroscience. 1999;94(3):745-53
10579565
Neuroscience. 1999;94(2):453-63
10579208
Neuroscience. 1998 May;84(2):413-29
9539213
Neural Plast. 2000;7(1-2):133-46
10709220
Neuroscience. 1993 Apr;53(4):981-91
8506031
Brain Res. 1998 Apr 20;790(1-2):33-44
9593812
Exp Brain Res. 1998 Feb;118(3):361-72
9497143
Brain Res. 1993 Jun 18;614(1-2):21-8
7688646
Brain Res. 1982 Dec 16;253(1-2):173-83
6295549
Prog Brain Res. 1991;88:521-32
1813932
Exp Brain Res. 1985;59(3):497-506
4029326
Brain Res. 1975 Mar 21;86(2):229-42
234774
Neuroscience. 1993 Apr;53(4):971-9
8506030
J Comp Neurol. 1998 Jun 8;395(3):310-27
9596526
Zh Vyssh Nerv Deiat Im I P Pavlova. 2002 Mar-Apr;52(2):195-204
12013656
Drugs Aging. 1994 Aug;5(2):116-26
7981483
Neuropharmacology. 1988 Apr;27(4):391-8
2843779
Ann N Y Acad Sci. 1984;430:7-25
6146285
Brain Res. 1993 Jun 18;614(1-2):191-6
8102313
Neuroscience. 1997 Dec;81(4):893-926
9330355
J Comp Neurol. 1988 Sep 22;275(4):511-41
3192756
Commun Psychopharmacol. 1980;4(1):83-90
7398246
Brain Res Bull. 1979 Jul-Aug;4(4):491-5
314836
J Neurophysiol. 1981 Nov;46(5):1140-59
7299451
Neurosci Res. 2001 Jan;39(1):71-7
11164254
Electroencephalogr Clin Neurophysiol. 1965 Jul;19:25-33
14325384